Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Study
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 06 Sep 2019
Price : $35 *
At a glance
- Drugs Mirabegron (Primary) ; Tamsulosin
- Indications Erectile dysfunction
- Focus Therapeutic Use
- 02 Sep 2019 Planned End Date changed from 1 Aug 2019 to 1 Jan 2020.
- 02 Sep 2019 Planned primary completion date changed from 1 Aug 2019 to 1 Jan 2020.
- 02 Sep 2019 Status changed from recruiting to active, no longer recruiting.